James Platt
@Jplatt_19
Followers
143
Following
4K
Media
10
Statuses
190
Med onc reg + research fellow @UniversityLeeds. Yorkshireman. Increasingly frustrated @drfc_official fan. Schedule based around ☕ access.
Leeds, England
Joined September 2017
1
0
4
Huge thank you to collaborators @chrisjmwilliams @JenSeligmann @DamianTolan @DrJamesGlasbey @sara_lonardi1 @ModestDominik @FilippoPietran4 @KaiKeenShiu @AliceHuskinson @yorkshirecancer @LIMRLeeds.
0
2
2
Delighted to have this published. Fantastic effort from all involved!. ✅ ICIs transforming Tx of dMMR CRC.✅ Common toxicities now well recognised but. 💥 Is bowel obstruction a rare complication when primary tumour in situ?!. International case series in @ESMO_Open ⬇️⬇️⬇️
1
9
22
RT @yorkshirecancer: 🔍 @FoxtrotStudy is an international clinical trial exploring whether giving specific groups of patients a course of ch….
0
2
0
RT @TheBMA: The NHS in England faces huge challenges. Today we submitted data to the Darzi Review on the key areas of concern. Here's a t….
0
138
0
RT @implausibleblog: Dr Marie Tolan, "We have been in dispute with the Conservative government for 20 months and they have failed to presen….
0
892
0
RT @drfc_official: We are delighted to confirm we have secured the return of Billy Sharp to the club on a one-year deal. Read more ⬇️.https….
0
329
0
😬 90% dMMR with wrong N stage were false-positives - huge implications for neoadj trial design.🩸N+ dMMR CC associated with ⬆️⬆️ inflammatory blood profile - potential to support staging? Needs validating!. Thanks to @JenSeligmann @DamianTolan @yorkshirecancer 👏.(2/2).
0
0
1
Pleased to get this out the door in @BJR_Radiology.🖥️ dMMR v pMMR CC important for radiology - rarely considered in existing radiology evidence-base.✅ Good at spotting T3/4 in pMMR + dMMR.❌ N staging poor in both at ~50% (🪙 flipping territory?) .(1/2).
2
5
13
Not possible without support from @yorkshirecancer @LeedsCancerRes @JenSeligmann @DamianTolan + many others. .
0
0
4
Delighted to have had the opportunity to attend + present @EsgarSociety #ESGAR23.💪 Hi-quality translational GI onc research.🤝 Opportunities for onc/rad collabs.🌞 Valencia weather not bad either. Leaving v inspired 🤯
2
3
17
RT @drlennardlee: 1/x #Cancercapacitychallenge @FinancialTimes V. Relevant #cancer. It's interesting with good & also worrying stories. ….
0
20
0
RT @yorkshirecancer: Supporters, researchers and people affected by cancer have gathered to complete the first mile of #StepOutYorkshire at….
0
4
0
RT @ACTION_Leeds: 🚨 Journal club tomorrow 🚨. Please join us for our next journal club tomorrow at 2pm, where @DrSallyMartin will be leading….
0
1
0
Super proud of @RosieMcNeillis for her MRCPCH 🧸 and reminding me who the smart 🍪 is around here. Fancy day out for me though 🥂
0
0
7
RT @ACTION_Leeds: 🚨 January Journal Club 🚨. 📣 Join us tomorrow for the January 2023 ACTION Leeds journal club where we will be discussing t….
0
1
0
RT @JenSeligmann: Super - thanks for highlighting our @FoxtrotStudy results @guardian @GenEdwards @UniversityLeeds .
0
9
0
RT @JenSeligmann: 🥁🥁🥁Tweetorial .FOxTROT, the 1st ph 3 RCT of neoadjuvant chemo (NAC) in locally advanced colon cancer .We report that NAC….
0
133
0